|
Mar 17
|
11 Oversold Biotech Stocks To Buy Right Now
|
|
Mar 17
|
Regeneron Pharmaceuticals Insiders Sold US$26m Of Shares Suggesting Hesitancy
|
|
Mar 14
|
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
|
|
Mar 13
|
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
|
|
Mar 13
|
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
|
|
Mar 12
|
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
|
|
Mar 12
|
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
|
|
Mar 11
|
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
|
|
Mar 9
|
Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation?
|
|
Mar 9
|
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
|
|
Mar 8
|
2 Biotech Stocks to Buy Hand Over Fist in March
|
|
Mar 8
|
EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The Lancet
|
|
Mar 7
|
Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?
|
|
Mar 6
|
EXEL vs. REGN: Which Stock Is the Better Value Option?
|
|
Mar 5
|
2seventy bio Inc (TSVT) Reports Mixed Financial Results Amid Strategic Shift and Competitive ...
|
|
Mar 4
|
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
|
|
Mar 4
|
Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their impressive 139% return over the last five years
|
|
Jan 30
|
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jan 30
|
Gear Up for Regeneron (REGN) Q4 Earnings: Wall Street Estimates for Key Metrics
|
|
Jan 30
|
Fate Therapeutics (FATE) Soars 25.4%: Is Further Upside Left in the Stock?
|